Efficacy of combination therapy with trandolapril and verapamil SR in primary hypertension: A 4 x 4 trial design

Clinical and Experimental Hypertension

Volumn 19, Issue 3, 1997, Pages 373-387

  DeQuattro, Vincent ^a   Lee, Deping ^a   Messerli, Franz ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b OCHSNER MEDICAL CENTER   (United States)

Author keywords

ACE inhibitor; calcium channel blocker; combination therapy; hypertension therapy

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; TRANDOLAPRIL; VERAPAMIL;

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NOSE CONGESTION; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; VERTIGO;

EID: 0030912669     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.3109/10641969709080825     Document Type: Article

References (22)

1. The Fifth Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1993; 153(2): 154-183.
2. DeQuattro V. Benazepril compared with other antihypertensive agents, singly and in combination - a review. In: H. R. Brunner, A. Salvetti, P.S. Sever (eds) , Benazepril: Profile of a New Ace Inhibitor. Royal Society of Medicine Services, Ltd., 1990.
3. Frishman WH, Bryzinski BS, Coulson LR, et al. A multifactorial trial design to assess combination therapy in hypertension. Arch Int Med. 1994; 154: 1461-1468.
4. Egashira K, Pipers FS, Rush J, Morgan JP. Effects of calcium channel blockers on coronary vasoconstriction induced by endothelin-1 in closed chest pigs. JACC. 1990; 16(5): 1296-1303.
5. Clozel M, Kuhn H, Fefti F. Effects of angiotensin converting enzyme inhibitors and of hydrazaline on endothelial function in hypertensive rats. Hypertension. 1990; 16: 532-540.
6. Bond MG, Strickland HL, Wilmoth SK, et al. Interventional clinical trials using noninvasive ultrasound end points: The Multicenter Isradipine/Diuretic Atherosclerosis Study. J Cardiovasc Pharm. 1990; 15(Suppl 1): S30-S33.
7. Weber KT, Sun Y. Structural remodeling in hypertensive heart disease and the role of hormones. Hypertension. 1994; 23: 869-877.
8. Asmar RG, Iannascoli F, Benetos A, Safar ME. Dose optimization study of arterial changes associated with angiotensin converting enzyme inhibition in hypertension. J of Hypertension. 1992; (Suppl 5): S13-S19.
9. McVeigh GE, Burns DE, Finkelstein SM, et al. Reduced vascular compliance as a marker for essential hypertension. Am J Hypertension. 1991; 4: 1-7.
10. O'Rourke M. Arterial mechanics and wave reflection with antihypertensive therapy. J of Hypertension. 1992; 10 (Suppl 5): S43-S49.
11. Dahlof B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy In hypertensive patients. Am J Hypertens 1992; 5:95-110.
12. Kramer BL, Massie BM, Topic N. Controlled trial of captopril in CHF. Circulation. 1983; 4: 807-816.
13. Petrella RJ, Nichol PM, Cunningham DA, et al. Verapamil improves left ventricular filling and. exercise performance in hypertensive and normotensive elderly individuals. Can J Cardiol 1994; 10:973-981.
14. Kasiske B, Kalil R, Ma J, et al. Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Int Med. 1993; 118: 129-138.
15. Bakris G, Barnhill B, Sadler R. Treatment of arterial hypertension in diabetic humans. Importance of therapeutic selection. Kidney Int. 1992; 41: 912-919.
16. Munter K, Safer A, Cries J, et al. Antihypertensive effect of verapamil-trandolapril combination in hypertensive rats. Am J Hypertension. 1995; 8:175A-185A.
17. Munter K, Cries J, Hergenroder S, et al. Effect of a verpamiltrandolapril combination on hypertension, renal failure and survival of SHRSP. Am J Hypertension. 1995; 8(4 Pt 2):176A.
18. Snappin SM. Evaluating the efficacy of a combination therapy. Statistics in Med 1987; 6:657-665.
19. Saunders E, Weir MR, Kong W. et al. A comparison of the efficacy and safety of a B-blocker, a calcium channel blocker, and a converting enzyme inhibitor in hypertensive blacks. Arch Int Med. 1990; 150: 1707-1713.
20. Cesarone MR, de Santis MT, Laurora G, Belcaro G, Effect of trandolapril on 24-h ambulatory blood pressure in patients with mild to moderate hypertension. J Cardiovasc Pharmacol. 1994; 23(Suppl 4): S65-S71.
21. Jain AK, McMahon FG. 24-Hour Blood pressure response to two slow-release verapamil formulations in patients with mild to moderate hypertension. Cardiovasc Reviews & Reports. 1993; 14(4): 45-51.
22. DeQuattro V. Individualization of therapy for hypertension in the 1990's: The role of calcium antagoists. Clin & Exper Hypertension 1994; 16(6):853-864.